← Back to Patent Explorer
US4918166A Expired / Lapsed US ⏱️ 0.0 years remaining

Particulate hybrid HIV antigens

Assignee: Vernalis R&D Ltd
•
Filing: 1987-10-26
•
Granted: 1990-04-17
•
Expires: 2007-10-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Fusion proteins comprise a77 first amino acid sequence and a second amino acid sequence. The first amino acid sequence is derived from a retrotransposon or an RNA retrovirus and confers on the fusion protein the ability to assemble into particles; an example is the product of the YTA gene of the yeast retrotransposon Ty. The second amino acid sequence is an HIV antigen. So particles formed of the fusion proteins may be useful in vaccines or in diagnostic or purification applications.

Inventors

  • 👤 Alan J. Kingsman
  • 👤 Susan M. Kingsman
  • 👤 Sally E. Adams

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 05:40
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/87; C12N15/90; C07; C07K; C07K14/00; C07K14/005; C12N15/11; C12N15/62; C12N15/63; C12N15/79; C12N15/80; C12N15/81; C07K2319/00; C07K2319/40; C12N2740/00; C12N2740/00011; C12N2740/10011; C12N2740/16011; C12N2740/16111; C12N2740/16122; Y; Y10; Y10S; Y10S530/00; Y10S530/806; Y10S530/81; Y10S530/812; Y10S530/82; Y10S530/823; Y10S530/824; Y10S530/826

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 60 words
A particle comprising a plurality of fusion proteins, each fusion protein comprising a first amino acid sequence and a second amino acid sequence, wherein the first amino acid sequence is substantially homologous with a particle-forming protein encoded by a yeast TYA gene without TYP gene sequence and wherein the second amino acid sequence is substantially homologous to an HIV antigen.
Claim 2
Dependent Claim 60 words
A particle comprising a plurality of fusion proteins, each fusion protein comprising a first amino acid sequence and a second amino acid sequence, wherein the first amino acid sequence is substantially homologous with a particle-forming protein encoded by a yeast TYA gene without TYP gene sequence and wherein the second amino acid sequence is substantially homologous to an HIV antigen.
Claim 3
Dependent Claim 13 words
A diagnostic reagent comprising particles of claim 7 dispersed on a solid support.
Claim 4
Dependent Claim 28 words
A particle according to claim 7 wherein the second amino acid sequence is immunologically reactive to antibodies which are immunologically reactive to HIV proteins p24, p41 or p120.

References Cited (Backward Citations)

US4722840A Cited
WO1986007090A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-04-16 1993-10-16 1994-04-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-04-16 1997-10-16 1998-04-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-04-16 2001-10-16 2002-04-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag